Strata Critical Medical, Inc.

Strata Critical Medical, Inc.

SRTA
Strata Critical Medical, Inc.US flagNASDAQ Global Market
5.06
USD
-0.09
- -
437.82MMarket Cap
2019 Y
2020 Y
2021 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.23
1.87
0.72
- -
2.04
3.06
1.85
2.27
3.03
Basic EPS, GAAP
-0.43
-0.81
-0.57
- -
-0.38
-0.76
-0.34
0.48
0.56
Free Cash Flow per Basic Share
-0.44
-0.89
-0.23
- -
-0.53
-0.47
-0.42
-0.67
-0.68
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-2.97
-1.1
- -
-1.45
-2.17
-2.35
-1.68
-1.71
Tangible Book Value per Share
- -
0.84
3.78
- -
2.63
2.36
2.5
1.65
1.8
Basic Weighted Avg Shares
25
13
70
- -
72
74
79
87
84
Sales/Revenue/Turnover
31
23
51
- -
146
225
147
197
254
Operating Margin (%)
-37
-44.21
-47.68
- -
-36.63
-30.25
-15.34
-11.34
-7.85
Depreciation Expense
- -
1
1
- -
6
7
6
8
10
Net Income, GAAP
-11
-10
-40
- -
-27
-56
-27
41
47
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-34.74
-43.36
-79.27
- -
-18.66
-24.9
-18.6
20.97
18.48
Working Capital
- -
8
305
282
192
171
138
106
103
LT Debt
- -
- -
- -
- -
15
20
2
3
3
Total Equity
- -
11
291
291
274
234
222
279
286
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
86
87
87
Market Capitalization
409
397
351

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
122
126
124
Cash, Cash Equivalents & STI
76
61
59
Accounts Receivable, Net
38
40
40
Inventories
- -
- -
- -
Total Current Liabilities
28
20
21
Payables & Accruals
27
19
20
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
0.02%
25.74%
Free Cash Flow
- -
- -
75.28%
Net Income, GAAP
- -
- -
-251.42%
Sales/Revenue/Turnover
- -
- -
34.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
52
68
36
54
147
2025
36
71
49
67
197
2026
67
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.06
-0.15
-0.03
-0.12
-0.34
2025
-0.04
-0.05
0.7
-0.1
0.48
2026
0.03
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Melissa Tomkiel
Full Time Employees
601
Sector
Healthcare
Industry
Medical - Care Facilities
Address
31 Hudson Yards New York NY United States of America 10001
IPO Date
Nov 5, 2019
Business
Strata Critical Medical, Inc. delivers essential logistical operations and specialized medical support to healthcare organizations nationwide. The company serves as a vital air and ground network, primarily facilitating the urgent transportation of human organs for transplant. This entity, established in 2014 and based in New York, New York, recently transitioned its focus entirely to medical services. Formerly known as Blade Air Mobility, Inc., the company adopted its current name in August 2025, following the divestiture of its passenger business to Joby Aviation. Expanding its capabilities, Strata Critical Medical acquired Keystone Perfusion in September 2025, thereby integrating surgical organ recovery, perfusion, and comprehensive transplant services into its offerings. It now offers an integrated, one-call solution for donor organ recovery and placement, leveraging an asset-light network to ensure rapid and efficient service delivery.

Company News

APIChatGPT
  • Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant Logistics

  • Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform

  • Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?

  • Strata Acquires Louisville Perfusion Services

  • AIAI Holdings Corporation Announces Appointment of Board of Directors

  • Strata Critical Medical Announces Expiration of Warrants

  • Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript

  • Strata Critical Medical Announces First Quarter 2026 Results

  • Strata Acquires Ohio Valley Perfusion Associates

  • Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call

  • Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

  • Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth

  • Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript

  • Strata Critical Medical Announces Fourth Quarter 2025 Results

  • Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call

  • Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution

  • Strata Critical Medical: Likely Valuation Re-Rating After Q4 Earnings (Upgrade)

  • Strata Critical Medical, Inc. (SRTA) Analyst/Investor Day Transcript

  • Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance

  • Strata Critical Medical, Inc. (SRTA) Q3 2025 Earnings Call Transcript